|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Wisconsin Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WisconsinLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
OpGen, Inc.
| OpGen, Inc. 708 Quince Orchard Rd., Suite 160 Gaithersburg, MD 20878 | |
| | Phone: | (301) 869-9683 | Fax: | (301) 869-9684 | Year Established: | 2001 | Employees: | 50 | Ticker: | OPGN | Exchange: | NASDAQ | Main Contact: | Evan Jones, Chairman & CEO | | Other Contacts: | Terry Walker, Ph.D., Senior VP, R&D Geoffrey A. McKinley, Ph.D., Senior VP, R&D, Business Development Charles Thornton, M.B.A., Ph.D., RAC, VP, QA & RA Timothy Dec, CFO Robert McG. Lilley, CCO Vadim Sapiro, CIO
| | Company Description | OpGen is a leading innovator in the field of microbial genetics. The company has developed a platform for its proprietary Optical Mapping Technology. Optical Mapping is the first technology that bridges strain typing and sequencing to correlate phenotype to genotype for generating advances in fields such as biodefense, outbreak management, agriculture and clinical microbiology. The Argus™ Optical Mapping System and MapIt™ Optical Mapping Services deliver ordered, whole genome genetic maps from single DNA molecules. The platform provides automated, high resolution, whole genome analysis for strain typing, comparative genomics and sequence assembly of microbial genomes to the life sciences market. This de novo technology is free from the limitations of gel, PCR and sequencing-based methodologies and has broad molecular diagnostic applications that are currently in development. OpGen’s customers include biodefense organizations, leading genomic research centers, academic institutions, clinical research organizations and biotechnology companies. | |
|
|
|
|
|